Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer
Clinical trial NCT04381910 · COMPLETED
Trial details
- NCT number
- NCT04381910
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2023-03-04
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.